Impact of Immune Paralysis on the Prognosis of Newly Diagnosed Multiple Myeloma Patients: A Retrospective Analysis

被引：0
|
作者：
Lv, Guoqing [1 ]
Tian, Linlin [1 ]
Lv, Wenting [2 ]
机构：
[1] Xinxiang Med Univ, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China
[2] Pingdingshan Univ, Pingdingshan, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-133
引用
收藏
页码：S117 / S118
页数：2
相关论文
共 50 条
  • [1] Prognostic Implications of Immune Paralysis in Newly Diagnosed Multiple Myeloma
    Lv, Guoqing
    Tian, Linlin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S581 - S581
  • [2] The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma
    张珏
    China Medical Abstracts(Internal Medicine), 2023, 40 (03) : 189 - 190
  • [3] Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma
    Ng, Alvin C.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Drake, Matthew T.
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 397 - 400
  • [4] The Significance of Inflammatory Markers in the Prognosis of Newly Diagnosed Multiple Myeloma Patients
    Gui, Lin
    Wang, Fei
    Shi, Jinning
    Chen, Baoan
    BLOOD, 2020, 136
  • [5] Single agent lenalidomide in newly diagnosed multiple myeloma: a retrospective analysis
    Baz, Rachid
    Patel, Mehul
    Finley-Oliver, Elizabeth
    Lebovic, Daniel
    Hussein, Mohamad A.
    Miller, Kena C.
    Wood, Margaret
    Sher, Taimur
    Lee, Kelvin
    Chanan-Khan, Asher A.
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1015 - 1019
  • [6] Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis
    Gelli, Elisa
    Martinuzzi, Claudia
    Soncini, Debora
    Conticello, Concetta
    Ladisa, Francesco
    Giorgetti, Giulia
    Truffelli, Dario
    Traverso, Isabella
    Lai, Francesco
    Guolo, Fabio
    Miglino, Maurizio
    Cagnetta, Antonia
    Laudisi, Antonella
    Aquino, Sara
    Derudas, Daniele
    Di Raimondo, Francesco
    Coviello, Domenico A.
    Lemoli, Roberto M.
    Cea, Michele
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Risk of stroke in patients with newly diagnosed multiple myeloma: a retrospective cohort study
    Lee, Gin-Yi
    Lee, Yu-Ting
    Yeh, Chiu-Mei
    Hsu, Pei
    Lin, Ting-Wei
    Gau, Jyh-Pyng
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Tzeng, Cheng-Hwai
    Chiou, Tzeon-Jye
    Liu, Jin-Hwang
    Liu, Yao-Chung
    Liu, Chia-Jen
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) : 726 - 733
  • [8] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [9] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [10] Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
    Wei, Min
    Guo, Honggang
    Liu, Siwei
    Xu, Fangfang
    Zhang, Yin
    Shi, Jie
    Xu, Zhiwei
    Chen, Yuqing
    MEDICINE, 2021, 100 (41) : E27521
12345